Thursday, January 27, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



Diaz-Canel hails Mexico’s authorizing the use of Abdala vaccine

Diaz Canel, México, vacuna, abdala

Diaz-Canel hails Mexico’s authorizing the use of Abdala vaccine

Havana, Dec 30 (Prensa Latina) Cuba's President Miguel Diaz-Canel today highlighted the approval for emergency use in Mexico of the Aldala vaccine against Covid-19, which was developed and is being produced in the island.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

“Very good news for #Cuba and #Mexico. Our vaccine #Abdala, of proven efficacy, continues to insert itself in the world. This Emergency Use Authorization is a recognition of the talent and dedication of Cuban scientists,” the President wrote on Twitter.

On Wednesday, Cuba’s Biotechnology and Pharmaceutical Industries Group (BioCubafarma) reported on social media that, with this approval, Mexico can import the Abdala vaccine for use in the National Vaccination campaign against the SARS-CoV-2 virus in people over 19 years of age.

The immunogen, developed by scientists at the island’s Center for Genetic Engineering and Biotechnology, is 92.8% effective against the coronavirus, in a three-dose schedule, according to information from the institution.

Cuba developed five vaccine candidates against the coronavirus: Abdala, Soberana 01, Soberana 02, Soberana Plus and Mambisa, of which Abdala, Soberana 02 and Soberana Plus have already been approved and are vaccines with which the nation has immunized more than 90 percent of its population.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.